REGENXBIO Inc. employees and revenue per employee

RGNX · Biotechnology · $417M market cap

REGENXBIO Inc. had 371 employees at the end of fiscal Dec 2025, up 5.1% from a year earlier. Revenue for the year was $170M, up 104.5% from a year earlier, or $459K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

371

+5.1% YoY

Revenue

$170M

+104.5% YoY

Revenue / employee

$459K

Peer median $459K

Rank in industry

54 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2016
0553111061'16'17'18'19'20'21'22'23'24'25Revenue 3714Staff 347

Hover a year for the numbers.

RGNX employees and revenue by fiscal year
Year endingEmployeesRevenuePer employeeStaff YoYRevenue YoY
Dec 2025371$170M$459K+5.1%+104.5%
Dec 2024353$83.3M$236K+2.6%-7.7%
Dec 2023344$90.2M$262K-14.2%-19.9%
Dec 2022401$113M$281K+7.8%-76.0%
Dec 2021372$470M$1.26M+21.6%+204.3%
Dec 2020306$155M$505K+19.1%+338.7%
Dec 2019257$35.2M$137K+33.9%-83.9%
Dec 2018192$219M$1.14M+38.1%+2002.4%
Dec 2017139$10.4M$75K+29.9%+126.5%
Dec 2016107$4.6M$43K——

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years
306'20372'21401'22344'23353'24371'25
Revenue per employee, last six fiscal years
$505K'20$1.26M'21$281K'22$262K'23$236K'24$459K'25

REGENXBIO Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
MAZE
Maze Therapeutics, Inc.
125$168M$1.34M—
STOK
Stoke Therapeutics, Inc.
170$184M$1.08MEfficient growth
SNDX
Syndax Pharmaceuticals, Inc.
298$172M$578KEfficient growth
PHAT
Phathom Pharmaceuticals, Inc.
371$175M$472KLeaner
RGNX
REGENXBIO Inc.
371$170M$459KEfficient growth
RYTM
Rhythm Pharmaceuticals, Inc.
414$190M$458KHiring ahead
MRVI
Maravai LifeSciences Holdings, Inc.
435$186M$427KContracting
DNA
Ginkgo Bioworks Holdings, Inc.
485$170M$351KContracting
BEAM
Beam Therapeutics Inc.
511$140M$273KEfficient growth
Every Healthcare company

Questions about REGENXBIO Inc.

How many employees does REGENXBIO Inc. have?
REGENXBIO Inc. reported 371 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 5, 2026. That is up 5.1% from a year earlier.
What is REGENXBIO Inc.'s revenue per employee?
REGENXBIO Inc. brought in $170M of revenue in fiscal Dec 2025, which is $459K per employee. That ranks 54 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare RGNX with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in REGENXBIO Inc.'s annual reports (Form 10-K), latest filed March 5, 2026. This is data, not a recommendation to buy or sell RGNX.